Gall Matthew 4
4 · iTeos Therapeutics, Inc. · Filed Jun 25, 2021
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-24+24,000→ 24,000 totalExercise: $23.19Exp: 2031-06-24→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 4 years, with 25% vesting on June 24, 2022 and thereafter in equal monthly installments over the next 36 months subject to the Reporting Person's continued service to the Issuer.